TMHC vs. NVO
TMHC (Taylor Morrison Home Corporation) and NVO (Novo Nordisk A/S) are both stocks. TMHC operates in Residential Construction (Consumer Cyclical), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, TMHC returned 17.21%/yr vs 7.56%/yr for NVO. At a 0.22 correlation, their price movements are largely independent.
Performance
TMHC vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMHC achieves a 22.13% return, which is significantly higher than NVO's -10.74% return. Over the past 10 years, TMHC has outperformed NVO with an annualized return of 17.21%, while NVO has yielded a comparatively lower 7.56% annualized return.
TMHC
- 1D
- -0.01%
- 1M
- 26.25%
- YTD
- 22.13%
- 6M
- 14.86%
- 1Y
- 23.90%
- 3Y*
- 15.27%
- 5Y*
- 20.87%
- 10Y*
- 17.21%
NVO
- 1D
- -0.18%
- 1M
- -4.19%
- YTD
- -10.74%
- 6M
- -9.50%
- 1Y
- -42.47%
- 3Y*
- -15.59%
- 5Y*
- 2.92%
- 10Y*
- 7.56%
TMHC vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TMHC Taylor Morrison Home Corporation | 22.13% | -3.82% | 14.73% | 75.78% | -13.19% | 36.30% | 17.34% | 37.48% | -35.02% | 27.05% |
NVO Novo Nordisk A/S | -10.74% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between TMHC and NVO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2013 | 0.22 |
Fundamentals
TMHC:
$7.01B
NVO:
$195.21B
TMHC:
$6.75
NVO:
DKK 27.42
TMHC:
10.65
NVO:
10.34
TMHC:
0.66
NVO:
0.44
TMHC:
0.94
NVO:
3.85
TMHC:
1.12
NVO:
6.21
TMHC:
$7.61B
NVO:
DKK 327.80B
TMHC:
$1.71B
NVO:
DKK 268.30B
TMHC:
$1.00B
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMHC vs. NVO — Risk / Return Rank
TMHC
NVO
TMHC vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Taylor Morrison Home Corporation (TMHC) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMHC | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.38 | ||
| Sortino ratioReturn per unit of downside risk | +2.37 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.85 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 0.89 | -0.80 | +1.69 |
| Martin ratioReturn relative to average drawdown | 1.66 | -1.18 | +2.84 |
Loading charts...
Drawdowns
TMHC vs. NVO - Drawdown Comparison
The maximum TMHC drawdown since its inception was -75.18%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for TMHC and NVO.
Loading charts...
Drawdown Indicators
| TMHC | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.18% | -74.70% | -0.48% |
Max Drawdown (1Y)Largest decline over 1 year | -23.80% | -54.34% | +30.54% |
Max Drawdown (3Y)Largest decline over 3 years | -27.90% | -74.70% | +46.80% |
Max Drawdown (5Y)Largest decline over 5 years | -40.84% | -74.70% | +33.86% |
Max Drawdown (10Y)Largest decline over 10 years | -75.18% | -74.70% | -0.48% |
Current DrawdownCurrent decline from peak | -3.88% | -68.11% | +64.23% |
Average DrawdownAverage peak-to-trough decline | -20.26% | -17.79% | -2.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.79% | 37.62% | -24.83% |
Volatility
TMHC vs. NVO - Volatility Comparison
Taylor Morrison Home Corporation (TMHC) has a higher volatility of 21.03% compared to Novo Nordisk A/S (NVO) at 10.68%. This indicates that TMHC's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TMHC | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.03% | 10.68% | +10.35% |
Volatility (6M)Calculated over the trailing 6-month period | 29.55% | 38.04% | -8.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.09% | 51.88% | -12.79% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.83% | 38.33% | -0.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.77% | 32.56% | +12.21% |
Dividends
TMHC vs. NVO - Dividend Comparison
TMHC has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.11%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 4.11% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
TMHC Taylor Morrison Home Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TMHC vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Taylor Morrison Home Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TMHC vs. NVO - Profitability Comparison
TMHC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported a gross profit of 290.64M and revenue of 1.39B. Therefore, the gross margin over that period was 21.0%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
TMHC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported an operating income of 141.79M and revenue of 1.39B, resulting in an operating margin of 10.2%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
TMHC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Taylor Morrison Home Corporation reported a net income of 100.43M and revenue of 1.39B, resulting in a net margin of 7.2%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
TMHC and NVO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMHC has higher volatility (21.03%) compared to NVO (10.68%). In terms of maximum drawdown, TMHC dropped -75.18% vs NVO's -74.70%.
TMHC currently has the higher Sharpe Ratio (0.54 vs -0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TMHC and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer